Julian Baker - Net Worth and Insider Trading

Over the past 18 months, Julian Baker made no insider transaction in IGM Biosciences Inc (IGMS). Other recent insider transactions involving IGM Biosciences Inc (IGMS) include a net sale of 11,918 shares made by George Gauthier , a net sale of 20,975 shares made by Bruce Keyt , and a net sale of 14,987 shares made by Lisa Lynn Decker .

In summary, during the past 3 months, insiders sold 28,125 shares of IGM Biosciences Inc (IGMS) in total and bought 395,317 shares, with a net purchase of 367,192 shares. During the past 18 months, 204,745 shares of IGM Biosciences Inc (IGMS) were sold and 1,190,933 shares were bought by its insiders, resulting in a net purchase of 986,188 shares.

IGM Biosciences Inc (IGMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Incyte Corp (INCY). Other recent insider transactions involving Incyte Corp (INCY) include a net sale of 57,275 shares made by Steven H Stein , a net sale of 24,981 shares made by Vijay K Iyengar , and a net sale of 2,500 shares made by Thomas Tray .

In summary, during the past 3 months, insiders sold 0 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 155,648 shares of Incyte Corp (INCY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 155,648 shares.

Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Kodiak Sciences Inc (KOD). Other recent insider transactions involving Kodiak Sciences Inc (KOD) include a net sale of 4,197 shares made by John A. Borgeson , and a net sale of 3,390 shares made by Jason Ehrlich .

In summary, during the past 3 months, insiders sold 0 shares of Kodiak Sciences Inc (KOD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,587 shares of Kodiak Sciences Inc (KOD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,587 shares.

Kodiak Sciences Inc (KOD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Prelude Therapeutics Inc (PRLD). Other recent insider transactions involving Prelude Therapeutics Inc (PRLD) include a net purchase of 32,944 shares made by Krishna Vaddi , a net purchase of 15,000 shares made by Laurent Chardonnet , and a net purchase of 869,565 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 0 shares of Prelude Therapeutics Inc (PRLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,280 shares of Prelude Therapeutics Inc (PRLD) were sold and 1,789,474 shares were bought by its insiders, resulting in a net purchase of 1,776,194 shares.

Prelude Therapeutics Inc (PRLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 96,513 shares made by John Paolini , a net sale of 83,336 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .

In summary, during the past 3 months, insiders sold 108,277 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 108,277 shares. During the past 18 months, 225,909 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,909 shares.

Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Atreca Inc (BCEL). Other recent insider transactions involving Atreca Inc (BCEL) include a net sale of 34,668 shares made by Tito Serafini , a net sale of 11,137 shares made by Phillips Courtney , and a net sale of 274,739 shares made by Baker Bros. Advisors Lp .

In summary, during the past 3 months, insiders sold 20,788 shares of Atreca Inc (BCEL) in total and bought 0 shares, with a net sale of 20,788 shares. During the past 18 months, 353,058 shares of Atreca Inc (BCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,058 shares.

Atreca Inc (BCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in BeiGene Ltd (BGNE). Other recent insider transactions involving BeiGene Ltd (BGNE) include a net sale of 159,928 shares made by John Oyler , a net sale of 82,635 shares made by Xiaodong Wang , and a net sale of 13,539 shares made by Xiaobin Wu .

In summary, during the past 3 months, insiders sold 100,397 shares of BeiGene Ltd (BGNE) in total and bought 0 shares, with a net sale of 100,397 shares. During the past 18 months, 5,517,082 shares of BeiGene Ltd (BGNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,517,082 shares.

BeiGene Ltd (BGNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in ACADIA Pharmaceuticals Inc (ACAD). Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 300,905 shares made by Stephen Davis , a net sale of 32,184 shares made by Brendan Teehan , and a net sale of 17,770 shares made by James Kihara .

In summary, during the past 3 months, insiders sold 69,383 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 69,383 shares. During the past 18 months, 433,237 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 463,285 shares.

ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Seagen Inc (SGEN). Other recent insider transactions involving Seagen Inc (SGEN) include a net sale of 36,447 shares made by Jean I Liu , a net sale of 46,232 shares made by Roger D Dansey , and a net sale of 161,013 shares made by Todd E Simpson .

In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc (SGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 413,479 shares of Seagen Inc (SGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 413,479 shares.

Seagen Inc (SGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Zymeworks Inc (ZYME). Other recent insider transactions involving Zymeworks Inc (ZYME) include a net purchase of 5,868,900 shares made by Ecor1 Capital, Llc , a net sale of 8,654 shares made by Christopher Astle , and a net sale of 7,425 shares made by Neil Josephson .

In summary, during the past 3 months, insiders sold 0 shares of Zymeworks Inc (ZYME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 52,759 shares of Zymeworks Inc (ZYME) were sold and 5,868,900 shares were bought by its insiders, resulting in a net purchase of 5,816,141 shares.

Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net sale of 18,149 shares made by Priti Patel , a net sale of 4,639 shares made by Sean Michael Smith , and a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp .

In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,139 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 113,128 shares.

Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Aceragen Inc (ACGN). Other recent insider transactions involving Aceragen Inc (ACGN) include a net sale of 264,324 shares made by Atul Chopra , a net purchase of 21,147 shares made by Pillar Invest Corp , and a net sale of 3,283 shares made by Vincent Milano .

In summary, during the past 3 months, insiders sold 0 shares of Aceragen Inc (ACGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 273,476 shares of Aceragen Inc (ACGN) were sold and 26,965 shares were bought by its insiders, resulting in a net sale of 246,511 shares.

Aceragen Inc (ACGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in HOOKIPA Pharma Inc (HOOK). Other recent insider transactions involving HOOKIPA Pharma Inc (HOOK) include a net purchase of 27,000 shares made by Reinhard Kandera , and a net purchase of 20,000 shares made by Jorn Aldag .

In summary, during the past 3 months, insiders sold 0 shares of HOOKIPA Pharma Inc (HOOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HOOKIPA Pharma Inc (HOOK) were sold and 47,000 shares were bought by its insiders, resulting in a net purchase of 47,000 shares.

HOOKIPA Pharma Inc (HOOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Invitae Corp (NVTAQ). Other recent insider transactions involving Invitae Corp (NVTAQ) include a net sale of 92,717 shares made by Kenneth D. Knight , a net sale of 89,529 shares made by Yafei Wen , and a net sale of 36,187 shares made by Robert L Nussbaum .

In summary, during the past 3 months, insiders sold 0 shares of Invitae Corp (NVTAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 332,151 shares of Invitae Corp (NVTAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 332,151 shares.

Invitae Corp (NVTAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Bellicum Pharmaceuticals Inc (BLCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bellicum Pharmaceuticals Inc (BLCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Bellicum Pharmaceuticals Inc (BLCM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 16,852 shares made by Jamie Christensen , a net sale of 12,809 shares made by Benjamin Hickey , and a net sale of 81,996 shares made by Charles M Baum .

In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 126,645 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,402,092 shares.

Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 81,925 shares made by Jennifer Chien , a net sale of 154,303 shares made by Joseph Shulman , and a net sale of 72,562 shares made by Hunter C Smith .

In summary, during the past 3 months, insiders sold 252,926 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 252,926 shares. During the past 18 months, 404,456 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 404,456 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 411,673 shares made by Jon P Stonehouse , a net sale of 10,125 shares made by Helen M. Thackray , and a net sale of 9,045 shares made by Michael L Jones .

In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 495,199 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 495,199 shares.

BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 11,996 shares made by Eliana Clark , a net sale of 12,645 shares made by Laura Sepp-lorenzino , and a net sale of 2,397 shares made by Muna Bhanji .

In summary, during the past 3 months, insiders sold 0 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 79,775 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 79,775 shares.

Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in XOMA Corp (XOMA). Other recent insider transactions involving XOMA Corp (XOMA) include a net purchase of 9,100 shares made by Bradley Sitko , a net purchase of 5,500 shares made by Owen Hughes , and a net purchase of 22,249 shares made by Biotechnology Value Fund L P .

In summary, during the past 3 months, insiders sold 0 shares of XOMA Corp (XOMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Corp (XOMA) were sold and 36,849 shares were bought by its insiders, resulting in a net purchase of 36,849 shares.

XOMA Corp (XOMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,486,744 shares made by Adam Morgan , and a net purchase of 50,000 shares made by William P Forbes .

In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc (HRTX) were sold and 2,536,744 shares were bought by its insiders, resulting in a net purchase of 2,536,744 shares.

Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Innoviva Inc (INVA). Other recent insider transactions involving Innoviva Inc (INVA) include a net purchase of 723,000 shares made by Alexander J Denner , a net sale of 10,994 shares made by Marianne Zhen , and a net purchase of 3,000 shares made by Pavel Raifeld .

In summary, during the past 3 months, insiders sold 0 shares of Innoviva Inc (INVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,994 shares of Innoviva Inc (INVA) were sold and 726,000 shares were bought by its insiders, resulting in a net purchase of 715,006 shares.

Innoviva Inc (INVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of XOMA Corp (XOMAO.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Corp (XOMAO.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XOMA Corp (XOMAO.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Talis Biomedical Corp (TLIS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Talis Biomedical Corp (TLIS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Talis Biomedical Corp (TLIS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in DBV Technologies SA (DBVT). Other recent insider transactions involving DBV Technologies SA (DBVT) include a net sale of 4,506 shares made by Pharis Mohideen , a net purchase of 17,094 shares made by Daniel Tasse , and a net purchase of 15,000 shares made by Daniel B Soland .

In summary, during the past 3 months, insiders sold 0 shares of DBV Technologies SA (DBVT) in total and bought 18,919 shares, with a net purchase of 18,919 shares. During the past 18 months, 4,506 shares of DBV Technologies SA (DBVT) were sold and 45,919 shares were bought by its insiders, resulting in a net purchase of 41,413 shares.

DBV Technologies SA (DBVT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Entrada Therapeutics Inc (TRDA). Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 54,092 shares made by Dipal Doshi , a net sale of 52,896 shares made by Kory James Wentworth , and a net sale of 43,405 shares made by Nathan J Dowden .

In summary, during the past 3 months, insiders sold 6,912 shares of Entrada Therapeutics Inc (TRDA) in total and bought 15,892 shares, with a net purchase of 8,980 shares. During the past 18 months, 218,034 shares of Entrada Therapeutics Inc (TRDA) were sold and 15,892 shares were bought by its insiders, resulting in a net sale of 202,142 shares.

Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in TScan Therapeutics Inc (TCRX). Other recent insider transactions involving TScan Therapeutics Inc (TCRX) include a net purchase of 67,027 shares made by Timothy J Barberich , a net sale of 25,400 shares made by Lynx1 Capital Management Lp , and a net purchase of 6,000 shares made by Brian M. Silver .

In summary, during the past 3 months, insiders sold 0 shares of TScan Therapeutics Inc (TCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,400 shares of TScan Therapeutics Inc (TCRX) were sold and 78,027 shares were bought by its insiders, resulting in a net purchase of 52,627 shares.

TScan Therapeutics Inc (TCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julian Baker made no insider transaction in Madrigal Pharmaceuticals Inc (MDGL). Other recent insider transactions involving Madrigal Pharmaceuticals Inc (MDGL) include a net purchase of 424,685 shares made by Baker Bros. Advisors Lp , a net sale of 29,800 shares made by Brian Joseph Lynch , and a net sale of 100,000 shares made by Paul A Friedman .

In summary, during the past 3 months, insiders sold 252,542 shares of Madrigal Pharmaceuticals Inc (MDGL) in total and bought 0 shares, with a net sale of 252,542 shares. During the past 18 months, 342,631 shares of Madrigal Pharmaceuticals Inc (MDGL) were sold and 424,685 shares were bought by its insiders, resulting in a net purchase of 82,054 shares.

Madrigal Pharmaceuticals Inc (MDGL)'s detailed insider trading history can be found in Insider Trading Tracker table.